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Abstract Herpesviridae constitutes a large family of
double-stranded DNA viruses that are associated with a
wide range of diseases, including herpetic lesions, birth
defects, and cancer. Herpesviruses establish lifelong latent
infections in part because they are exceptionally adept at
modulating the virus/host interface. New insights into the
numerous roles of microRNAs (miRNAs) in cell biology,
along with the recent appreciation that nearly every host
transcript is targeted by at least one miRNA, has funda-
mentally changed our conceptualization of the virus/host
relationship. The identification of miRNAs expressed from
nearly all human herpesvirus genomes has led to the
speculation that these short non-coding transcripts play
essential roles in herpesvirus biology. Because the activity
of miRNAs depends upon the transcriptome of the cell in
which they are expressed, in vivo systems will be essential
for defining the true biological relevance of herpesvirus
miRNAs. This review will specifically focus on experi-
mental systems which have investigated the functional role
of herpesvirus-encoded miRNAs in viral biology and
pathogenesis in vivo.
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Introduction
Over the past decade, the scientific world, including the
field of virology, has experienced an exponential growth in
the study of non-coding RNA functions. In particular, the
plethora of exciting new insights into the numerous roles of
microRNAs (miRNAs) in cell biology [1] and the appre-
ciation that nearly every host transcript is targeted by a
miRNA [2] has changed the landscape of our conceptual-
ization of the virus/host relationship. Although numerous
studies have detected the expression of mature miRNAs
from viruses within multiple genera, the early identification
of miRNAs in nearly all human herpesvirus genomes [3, 4]
has led to the speculation that these molecules play
essential roles in herpesvirus biology and pathogenesis.
The Herpesviridae constitutes a large family of envel-
oped, double-stranded DNA viruses that are associated with
a wide range of diseases in humans and animals. Members of
this virus family are classified into alpha-, beta-, and gamma-
subfamilies based on genomic organization and sequence
similarity. Unlike other viruses, following spread to a new
host herpesviruses typically undergo an acute lytic phase of
replication, and then establish lifelong latency in a distinct
cellular compartment. Thus herpesviruses are exceptionally
adept at modulating the host/virus interface. Although
miRNAs are likely key players in at least some stages of this
dynamic, their specific functional roles are currently poorly
understood.
miRNAs are small (*22 nucleotide) non-coding RNAs
that regulate mRNA translation [1]. Cellular processing of
the primary miRNA transcript leads to the release of a
stable pre-miRNA hairpin, which is typically further pro-
cessed by the cellular enzyme Dicer, yielding a miRNA
duplex. One strand of the miRNA duplex (the 50 or the 30
side of the hairpin, designated as the -5p or -3p strand
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miRNA accordingly) is then incorporated into the RNA-
induced silencing complex (RISC). In the RISC, the
miRNA and its target mRNA interact through base pairing
that typically requires full complementarity of 6–8
nucleotides called the miRNA seed sequence and thereby,
blocking mRNA translation. miRNAs are therefore
important regulatory factors whose activity depends upon
the transcriptome of the cell in which they are expressed.
For this reason, it is likely that the in vivo function of virus-
encoded miRNAs may not be easily extrapolated from
in vitro studies. Thus, experimental in vivo systems will be
essential for defining the true biological relevance of her-
pesvirus miRNAs. Although the in vivo expression profiles
for many viral miRNAs have been carefully elucidated, this
review will specifically focus on experimental systems
which have investigated the functional role of herpesvirus-
encoded miRNAs in the in vivo biology of viral infection.
Alphaherpesviruses
The alphaherpesvirus subfamily includes the well-known
human pathogens herpes simplex virus (HSV)-1 and HSV-2,
the causative agents of oral and genital herpetic lesions, and
varicella zoster virus (VZV), which causes chickenpox and
shingles. The pathogenic outcomes associated with these
alphaherpesvirus infections are directly related to the unique
ability of these viruses to establish lifelong latency in, and
periodically reactivate from, the peripheral nervous system.
While no viral miRNAs have thus far been detected during
VZV infection, both HSV-1 and -2 encode numerous miR-
NAs, some of which appear to play key roles in regulating
viral infection and pathogenesis. Fortunately, both HSV ser-
otypes are able to establish persistent infections in mice and
rabbits, providing robust model systems for studies of viral
latency and pathogenesis. Additionally, pseudorabies virus
(PRV) represents an important model system that mimics
many of the key features of HSV latency establishment in
neurons.Because PRVexhibits a broad host tropism, neuronal
PRV infections have been studied in a wide range of animals,
frommice to chickens to its natural host pigs. Finally,Marek’s
disease virus (MDV) is a highly important avian virus that has
been classified as alphavirus based on genomic structure and
sequence homology. However, MDV exhibits biological
properties, including infection of T cells and induction of T
cell lymphoma that more closely align with the gammaher-
pesvirus subfamily and serves as an excellent model system
for the study of herpesvirus lymphomagenesis.
Herpesvirus Simplex Virus-1 and -2
HSV-1 and -2 establish lifelong latent infections within
sensory neurons of the trigeminal ganglia (TG) and sacral
dorsal root ganglia (DRG), respectively. HSV-1 reactiva-
tion events induce a range of diseases from common oral
cold sores to herpes stromal keratitis to rare cases of
encephalitis, whereas HSV-2 reactivation from the DRG
typically results in genital herpetic lesions. HSV-1 and -2
encode 20 and 17 potential pre-miRNA stem-loops [5–9],
respectively, many of which are distributed in clusters
within and flanking the latency-associated transcript (LAT)
(Fig. 1). Although several pre-miRNAs display positional
homology between HSV-1 and HSV-2, with the exception
of three molecules that retain identical seed sequences
(hsv-miR-H2-3p, -H7-5p, -H11-3p), the mature HSV-1 and
-2 miRNAs display little sequence similarity [8].
Notably, initial work on the HSV-1 LAT-encoded
miRNAs suggested that although hsv1-miR-H2, -H4, -H5,
and -H6 were detectable in TGs during latency, these
molecules may be dispensable for latent infection: in wild-
type mice, LAT promoter mutants that lacked expression of
these miRNAs replicated normally and established wild-
type levels of latent infection [10]. However, further work
examining the function of individual molecules has led to
the conclusion that single miRNAs may play important
roles in infection which are obscured by combinatorial
miRNA mutations.
One HSV-1 miRNA of great interest is hsv1-miR-H2,
which lies antisense to and regulates translation of the key
immediate-early gene ICP0 (Fig. 1) [9], and displays a
seed sequence identical to its HSV-2 positional miRNA
homolog. To examine the importance of hsv1-miR-H2 for
in vivo infection, Jiang et al. constructed a precise mutant
on the highly virulent wild-type McKrae virus background
which disrupts the pre-miRNA structure, but retains the
amino acid sequence of ICP0, an E3 ubiquitin ligase that is
known to facilitate lytic replication and reactivation from
latency [11•]. Ocular infection of Swiss Webster mice with
the H2 mutant virus led to the increased penetrance of
herpes encephalitis as compared to the parental strain
(survival 86 vs 52 %); however, this was not due to
enhanced replication at the site of infection, as ocular titers
were equivalent between wild-type and mutant virus. In
contrast, whereas the number of latent viral genomes in the
TG were not statistically different at 30 days post-inocu-
lation (dpi) between the two viruses, TG explants from H2
mutant-infected mice demonstrated an increased rate of
reactivation from latency [11•], offering a potential
explanation for the observed increase in neurovirulence.
Consistent with this, mutation of neuron-specific miR-138,
which regulates ICP0 transcripts, results in increased neu-
rovirulence in vivo [12].
Of additional interest for both HSV-1 and HSV-2 are the
positional miRNA homologs at the miR-H6 position,
which lie just outside of the crucial LAT promoter (Fig. 1),
and are regulated by LAT promoter activity [10, 13].
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Moreover, hsv1-miR-H6 regulates the essential immediate-
early gene ICP4 [9]. Although hsv2-miR-H6 does not
directly regulate ICP4 [9, 14], ICP4 suppresses the
expression of other key LAT-encoded HSV-2 miRNAs
[13], suggesting that intricate regulation of the bidirec-
tional LAT promoter may play a critical role in regulation
of the balance between latency and reactivation. To
determine whether hsv2-miR-H6 played a key role in
in vivo infection, Tang et al. disrupted miR-H6 expression
by inserting an upstream poly(A) sequence, which abro-
gated miR-H6 expression but did not affect levels of HSV-
2 LAT or viral DNA copy number [14]. Following the
inoculation of mice (intraocular) or guinea pigs (intrav-
aginal), the polyA miR-H6 mutant replicated and estab-
lished latency in ganglia (TG for mice, DRG for guinea
pigs) at levels comparable to wild-type virus. Importantly
though, guinea pigs infected with the mutant displayed
complete attenuation of neurological symptoms (0 % for
the mutant, compared to 37.5 and 62.5 % for revertant and
wild-type HSV-2, respectively), demonstrating a key role
for hsv2-miR-H6 in HSV-2 pathogenesis through unknown
means likely involving regulation of multiple host and viral
components.
Pseudorabies Virus
Pseudorabies virus (PRV, SuHV-1) is a highly contagious
alphaherpesvirus that primarily infects swine, but also
infects a wide range of domestic livestock and forest-
dwelling mammals [15]. Although PRV infection is fre-
quently asymptomatic, infection of young animals can
result in severe neurological, respiratory, and reproductive
system manifestations which are characteristic of
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Fig. 1 Genomic locations of herpesvirus miRNAs. Genomic maps
indicate the number of miRNA stem-loops and approximate locations
of miRNAs relative to one another and to nearby transcripts. Pre-
miRNA stem-loops depicted above genomes are forward transcribed
and those depicted below genomes are reverse transcribed. Nearby
coding genes are represented by black arrows, and adjacent non-
coding transcripts are represented by green lines. HSV-1, HSV-2, and
MDV-1 encode miRNA precursors within both the internal and
terminal repeats, as indicated. Depictions of genomes and transcripts
are not to scale (Color figure online)
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PRV infection can result in nearly 100 % fatality of
piglets [15].
Following intranasal inoculation, PRV establishes
latency in the neurons of TG. During in vivo latency, the
LAT locus is the only region of the PRV genome that is
transcriptionally active. The largest transcript within the
LAT locus is the full-length, 8.4 kb polyadenylated large
latency transcript (LLT), which is expressed at high levels
during latency and is spliced to yield a 4.6 kb stable intron
[16]. Recent work has demonstrated that the PRV LLT
functions in part as a primary miRNA precursor which
encodes 11 pre-miRNA stem-loops, all located within the
LLT intron (Fig. 1) [7, 17, 18]. To determine the function
of PRV miRNAs during in vivo infection, Mahjoub, et al.
generated a cluster deletion mutant that lacked 9 of the 11
PRV pre-miRNA stem-loops [19•].
Following i.n. infection of German Landrance pigs,
the mutant virus replicated in nasal swabs to levels
slightly higher than wild-type virus, demonstrating that
these PRV miRNAs are dispensable for acute replication.
Similarly, despite detecting expression of the miRNAs
from the WT virus genome in TG, deletion of the
9-cluster miRNAs had little effect on latency establish-
ment, as determined by PCR for viral genome at 62 dpi.
Although these results did not reveal a crucial role for
these PRV miRNAs during in vivo infection, the effects
of the remaining PRV miRNAs in pathogenesis remain
to be determined.
Marek’s Disease Virus
Marek’s disease virus-1 (MDV-1, GaHV-2) is a highly
contagious avian alphaherpesvirus that is the causative
agent of the T-cell lymphoma for which it is named. Today,
MDV-1 infection of chickens represents an excellent
model system for studying virus-induced neoplastic dis-
eases [20, 21]. Although there are several circulating
MDV-1 strains, it is important to note that individual
strains vary in virulence, and have thus been classified as
mild (m), virulent (v), very virulent (vv), and very virulent
plus (vv?) [22]. While the penetrance of disease and the
time of onset vary with strain virulence, MDV-1 infection
reproducibly results in T-cell lymphoma in a wide range of
chicken lines. As a result, MDV-1 lymphomagenesis has
offered perhaps the most direct and important means by
which to define a central role for virus-encoded miRNAs in
tumorigenesis.
MDV-1 encodes a total of 14 pre-miRNAs, each of
which are duplicated within their respective terminal and
internal repeat regions (Fig. 1) [7, 23, 24]. As for other
herpesviruses, the MDV-1 miRNAs are clustered, with two
clusters surrounding the important meq oncogene and
another cluster incorporated within the LAT. Interestingly,
several MDV-1 miRNAs are much more highly expressed
in tumor tissue than non-tumor tissue, suggesting the pos-
sibility that the miRNAs may contribute to lymphomage-
nesis [25]. Moreover, only miRNAs from the Meq cluster
are differentially expressed by the very virulent strains of
MDV-1, leading to the speculation that these miRNAs play
a greater role in disease progression [26].
To define the contribution of MDV-1 miRNAs to
neoplastic growth in vivo, multiple research groups have
generated specific miRNA mutants on parental MDV-1
strains of varying virulence. In a seminal manuscript for
the viral miRNA community, Zhao, et al. compared
tumorigenesis of the virulent pRB-1B5 (a BAC-contain-
ing version of RB-1B) strain to a mutant of the parental
strain lacking expression of the cluster of six miRNAs
lying upstream of Meq [27]. While wild-type virus was
lethal in 100 % of animals within 7–8 weeks post-inoc-
ulation, pRB-1B5 lacking expression of these six miR-
NAs was completely attenuated. Surprisingly, a two
nucleotide seed sequence mutant of the single miRNA
mdv1-miR-M4, a functional ortholog of the important
cellular oncomir miR-155 [28], was equally attenuated
for lethality, resulting in 100 % survival of infected
animals. Thus, these data demonstrated an essential role
for mdv1-miR-M4 in MDV-1 lymphomagenesis, and
further substantiated the conclusion that miR-155 dys-
regulation can be a principal factor in the development of
lymphoid tumors.
It is notable that a mdv1-miR-M4 mutant on the back-
ground of the very virulent parental strain GX0101
demonstrated a slower onset of malignant disease, and
reduced but did not abolish disease penetrance (100 %
wild-type, 18 % miR-M4 mutant), indicating that M4 is not
absolutely essential for oncogenesis [29•]. Although this
study utilized a higher inoculation dose and increased
experimental time frame than the previous experiment,
these findings may indicate that additional viral factors
may also contribute to the pathogenesis of MDV-1 strains
with enhanced virulence. In support of this, Teng et al.
used additional single miRNA mutants to demonstrate
divergent roles for other Meq-clustered miRNAs in the
induction of MD lymphoma [30•]. While 100 % of parental
GX0101-infected birds succumbed to infection by 75 dpi,
individual mutants of mdv-1-miR-M2, -M3, -M5, -M9, or
-M1 displayed an incidence of disease ranging from 14 to
48 %, demonstrating a contribution of these additional
miRNAs to tumorigenesis. While the differences between
these studies must be carefully delineated in future work,
these findings clearly demonstrate an essential role for the
Meq-clustered miRNAs in the genesis of MDV-1-associ-
ated tumors.
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Betaherpesviruses
The most prominent member of the betaherpesvirus sub-
family is human cytomegalovirus (HCMV). HCMV is a
ubiquitous virus that is primarily asymptomatic in
immunocompetent humans, but is a very significant cause
of morbidity and mortality in patients with compromised
immunity, and is the leading cause of birth defects in
industrialized countries. Cytomegalovirus infections char-
acteristically induce a lytic infection in glandular epithelial
cells, particularly within the salivary gland, and establish
persistent infections that likely involve cycles of latency,
reactivation, and lytic infection. Betaherpesviruses such as
HCMV, and human herpesviruses-6A, -6B, and -7, are
highly species specific. Thus the development of experi-
mental animal models for the human viruses has not been
successful. Although the gene structure of murine cyto-
megalovirus (MCMV) differs significantly from that of
HCMV, MCMV exhibits important biological properties in
mice that overlap with that of HCMV in humans. Thus
MCMV infection of mice has served as an outstanding
model for understanding in vivo aspects of cytomegalo-
virus replication and pathogenesis, and has been a partic-
ularly valuable tool for defining the function of virus-
encoded genes in evasion of the immune response.
Murine Cytomegalovirus
HCMV encodes 11 pre-miRNA stem-loops yielding 17
detectable mature miRNAs, and MCMV encodes 18 pre-
miRNA stem-loops yielding up to 29 detectable mature
miRNAs [7, 31]; however, the HCMV and MCMV miR-
NAs exhibit little or no homology [32]. Nevertheless, as
has been the case for protein-coding genes, the study of
MCMV miRNAs is likely to elucidate valuable insights
into the complex relationship between betaherpesviruses
and their natural hosts.
MCMV miRNAs are arranged into three distinct clusters
which have been annotated as them01 cluster, the m21/m22/
m23 cluster, and the m107–m108 cluster (Fig. 1). To date,
only them21/m22/M23 cluster miRNAs have been carefully
characterized in vivo. Dolken et al. generated a virus with 17
point mutations in the pre-miRNA stem-loop of two of the
most highly expressedMCMVmiRNAs,mcmv-miR-M23-2
and mcmv-miR-m21-1 [33]. To determine the biological
relevance of these miRNAs in the context of in vivo infec-
tion, the authors intravenously infected both B6 and BALB/c
mice, andmeasured viral titers in salivary glands and lungs at
14 dpi. The salivary glands are the primary site of MCMV
replication and shedding, and are an immune-privileged site
from CD8 T cells, but not CD4 T cells and NK cells [34].
Although both BALB/c and B6 mice are susceptible to
MCMV infection, B6 mice much more efficiently control
salivary gland replication due to the presence of the acti-
vating NK cell receptor Ly49H. Interestingly, salivary gland
replication of the miR-M23/m21 mutant virus was attenu-
ated nearly 100-fold in B6 mice, but was reduced only
twofold in BALB/c mice, suggesting that NK cell-mediated
control is compromised in the absence of miR-M23/m21
expression [33]. Consistent with this conclusion, replication
of the mutant virus in B6 mice was restored to wild-type
levels upon NK cell depletion. Thus this work demonstrated
a key role for a MCMV miRNA in evasion of the immune
response, and was the first to demonstrate the in vivo
importance of a herpesvirus miRNA.
Gammaherpesviruses
The gammaherpesvirus subfamily includes the important
human pathogens Epstein–Barr virus (EBV) and Kaposi’s
sarcoma (KS)-associated herpesvirus (KSHV, HHV-8).
EBV is a highly ubiquitous human pathogen, chronically
infecting greater than 90 % of the adult human population
worldwide. Moreover, EBV infection is associated with the
development of numerous types of malignancies, including
Burkitt’s B-cell lymphoma, nasopharyngeal carcinoma
(NPC), and Hodgkin’s lymphoma. KSHV is a lym-
photropic gammaherpesvirus that infects endothelial cells
and establishes latency in mature circulating B cells.
KSHV infection is associated with a variety of malignan-
cies including KS, primary effusion lymphoma (PEL), and
multicentric Castleman’s disease (MCD).
Although an extensive amount of work has been direc-
ted toward defining the function of individual protein-
coding genes and non-coding RNAs during EBV and
KSHV infection in vitro, determining the specific roles that
these elements play in vivo is an enormous obstacle due to
their strict species specificity. Thus, an important advance
has come from the recent use of humanized mice, which
utilizes transplants of human hematopoietic stems cells
(HSCs) to partially reconstitute the immune systems of
severely immunocompromised mice [35]. However,
humanized mouse systems are extremely expensive, do not
support long-term infections, and by necessity employ
highly immunodeficient mouse strains; thus such models
are not optimal for understanding all aspects of virus/host
relationship. Nevertheless, humanized mouse systems
provide an opportunity to examine some in vivo functions
of human viral genes in the context of its parental virus.
Similarly, ectopic expression of viral genes or gene clusters
in adoptive immune reconstitution and transgenic mouse
studies have proved to be of successful means to define
functions of viral genes independent of virus infection.
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Like EBV and KSHV, murine gammaherpesvirus 68
(MHV68, cHV68, MuHV-4) establishes latent infection in
B cells and results in the induction of lymphoproliferative
disease and B-cell lymphoma in the setting of a compro-
mised immune system. Thus MHV68 infection of mice has
proven to be a facile and robust system for examining
cellular and molecular aspects of the complex relationship
between a gammaherpesvirus and its natural host.
Epstein–Barr Virus
Following transfer of virus to a naive host, EBV undergoes
lytic replication in the oral epithelium and establishes
lifelong latency in circulating memory B cells. Although
EBV infection is typically asymptomatic, acute or chronic
infection in the setting of immunocompromise or alongside
essential cofactors can lead to the development of multiple
types of epithelial or lymphoid malignancies. Thus
understanding the function of EBV miRNAs in the context
of B cell and epithelial biology is of utmost interest. The
172 kb EBV genome encodes 25 pre-miRNA stem-loops
that yield up to 44 mature miRNAs [7, 36]. The EBV
miRNAs are located in three distinct clusters, with one
cluster flanking the the Bcl-2 homolog BHRF1, and the
others located in two separate clusters within the BART
RNA transcript (Fig. 1).
To determine the in vivo function of the three BHRF1
cluster miRNAs, Wahl et al. generated a virus carrying
deletions of ebv-miR-BHRF1-1, ebv-miR-BHRF1-2, and
ebv-miR-BHRF1-3 [37•]. Following the direct injection of
virus into the spleens of humanized mice, the authors
observed a significant delay in the accumulation of the
mutant virus DNA in the peripheral blood as compared to
that of wild-type virus. However, this delay did not affect
overall pathogenesis, as the mutant virus resulted in a
similar penetrance of EBV? tumors. Thus, these results
indicated that the BHRF1-cluster miRNAs may facilitate
initial acute replication and systemic spread of EBV, but
that they do not play an essential role in EBV oncogenesis.
It is noteworthy that these in vivo findings contrast with the
established role of the BHRF1 miRNAs in potentiation of
B-cell transformation in vitro [38], which may suggest that
other virus or host factors perform activities redundant to
the BHRF1 miRNAs in an in vivo system.
Further work using an irradiated mouse model system
examined the role of the BART cluster 2 miRNA ebv-miR-
BART7-3p in promoting NPCmetastases. ebv-miR-BART7-
3p is highly expressed in NPC samples [39••] and positively
correlates with tumor metastasis and clinical stage. To
determine whether ebv-miR-BART7-3p facilitates metastatic
transition in vivo, Cai et al. generated EBV-negative NPC
cells lines stably expressing ebv-miR-BART7-3p. Cells were
then transplanted under the liver capsule of irradiated mice,
and lymph node metastases were observed after 3 weeks.
Consistent with in vitro findings, lymph nodemetastaseswere
observed in 83 % of mice transplanted with NPC cells
expressing ebv-miR-BART7-3p, compared to only 17 % of
mice transplanted with control NPC cells, suggesting that
ebv-miR-BART7-3p stimulates epithelial-to-mesenchymal
transition (EMT). The authors further demonstrated that this
transition was mediated at least in part through miRNA tar-
geting of the PI3K/Akt/GSK-3b pathway and subsequent
downregulation of PTEN [39••].
Kaposi’s Sarcoma-Associated Herpesvirus
KSHV encodes 12 pre-miRNAs which yield 25 detectable
mature miRNAs (Fig. 1), all located within the latency-
associated region of the genome (10 in the intronic region
between the protein-coding genes K12 and v-FLIP, and 2
within the K12 ORF sequence). Due to the prominent role
of host miR-155 in B-cell differentiation and cancer [40],
the miR-155 ortholog kshv-miR-K12-11 has been of
tremendous interest. To determine whether kshv-miR-K12-
11 functions similar to miR-155 to facilitate B-cell devel-
opment, Boss et al., transplanted human hematopoietic
progenitors stably expressing miR-K12-11 or miR-155 into
NOD/LtSz-scid IL2Rcnull mice and monitored immune
reconstitution over time [41]. Importantly, ectopic expres-
sion of either kshv-miR-K12-11 or miR-155 guided a
significant expansion of human CD19? splenic B cells
compared with control mice. Validating these findings,
stable expression of kshv-miR-K12-11 in HSCs resulted in
mature B-cell expansion in the periphery and an increase in
the number of developing pre-B cells in the bone marrow
[42•]. Moreover, the latency locus of KSHV complemented
the B-cell development and response phenotype of miR-
155-deficient mice, demonstrating that miR-K12-11 indeed
can mimic miR-155 functions in vivo [43•, 44, 45].
Together, these studies demonstrated a highly important
functional role for kshv-miR-K12-11 in modulating B-cell
differentiation and provided great insight into the potential
for a single virus-encoded miRNA to potently alter the fate
of infected cells in vivo.
Murine Gammaherpesvirus 68
Murine gammaherpesvirus 68 (MHV68, cHV68, MuHV-4)
is a natural pathogen of wild rodents, including mice, and
MHV68 infection of laboratory mice has served as an
important model for the in vivo study of gammaherpesvirus
latency and pathogenesis. MHV68 encodes 14 pre-miRNA
stem-loops which yield up to 28 mature miRNAs [7, 46–
48]. Interestingly, the 14 stem-loop sequences are incor-
porated into 8 primary pol III transcripts (Fig. 1) that carry
a viral tRNA (vtRNA)-like element at the 50 end. These
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tRNA-miRNA-encoding RNAs (TMERs), which are
approximately 250 bp in length, are processed in a Drosha-
independent manner prior to entering the canonical miRNA
processing pathway. Although it has been long-known that
the TMER transcripts are highly expressed in latently
infected cells and in virus-associated malignancies [49,
50], a functional role for these miRNAs during infection
has only recently been uncovered.
Using differing approaches to generate combinatorial
miRNA mutant viruses, two groups, including our own,
have now demonstrated roles for the MHV68 miRNAs in
both latency and pathogenesis. Following intranasal inoc-
ulation of B6 mice with MHV68.Zt6, a recombinant
MHV68 with deletions of pre-miRNA stem-loops encoded
by TMERs 1–5, 7, and 8, and a transcriptional stop
upstream of the TMER6 miRNAs, underwent normal acute
replication in lungs in vivo, demonstrating that the MVH68
miRNAs are dispensable for lytic replication [51••]. Nev-
ertheless, this mutant displayed a 2.3-fold reduction in
latency establishment and reduced numbers of infected
memory B cells, suggesting that the virus-encoded miR-
NAs may facilitate differentiation of infected B cells dur-
ing latency establishment. Similarly, Diebel et al.
generated a combinatorial TMER mutant virus,
MHV68.TKO, which carries deletions in the pol III pro-
moters of each of the TMERs, and found that TMER
expression was dispensable for acute replication [52••]. In
contrast to the latency attenuation observed following
infection with MHV68.Zt6, the MHV68.TKO mutant dis-
played slightly elevated frequencies of infected cells at
14 dpi. However, the discrepancies between these two
mutants may be due to the lack of vtRNA expression by the
promoter mutant virus: while MHV68.Zt6 expresses nor-
mal levels of the TMER-encoded vtRNAs, MHV68.TKO
lacks expression of the entire TMER transcript including
vtRNAs. These findings may suggest that the virus-en-
coded vtRNAs themselves play a functional role in vivo.
Strikingly, despite these subtle latency phenotypes in
wild-type animals, the combinatorial miRNA mutant
viruses displayed an impressive attenuation of lethal
pneumonia in BALB/c mice deficient in IFNc. While only
20 % of mice infected with wild-type virus survive the
pulmonary inflammatory disease observed in these mice,
100 % of mice inoculated with MHV68.Zt6 survive
infection [51••]. Similarly, 80 % of mice infected with the
MHV68.TKO virus survive infection [52••]. Although the
specific targets of the MHV68 miRNAs are yet to be
resolved, together these reports demonstrate an essential
role for MHV68-encoded miRNAs in this robust model of
viral disease. Further, these findings also suggest that while
herpesvirus-encoded miRNAs may only subtly regulate
chronic infection, their presence may strongly influence the
development or outcome of disease.
Conclusions
Despite the rapid growth of miRNA research in recent
years, the understanding of the specific functions of virus-
encoded miRNAs during infection is still in its infancy. In
particular, due to their likely subtle and redundant effects,
defining the biological relevance of virus-encoded miRNAs
in in vivo systems poses a substantial hurdle. Yet, impor-
tant advances in the field have been made in the last few
years, and new themes appear to be emerging.
Herpesvirus miRNAs are Largely Dispensable
for Acute Replication
Experiments in the HSV-1, HSV-2, PRV, and MHV68
systems have clearly demonstrated that individual or
combinatorial miRNA mutant viruses are able to replicate
normally in vivo, a finding which is generally consistent
with parallel in vitro studies. Although an MCMV miRNA
mutant exhibited severely reduced titers in vivo, this
observation was definitively linked to evasion of NK cell
evasion, providing an elegant demonstration of the poten-
tial of a single viral miRNA to manipulate host immunity.
Herpesvirus miRNAs Significantly Contribute
to Pathogenesis
Importantly, despite the lack of obvious role for her-
pesvirus miRNAs in acute infection, and the apparently
subtle roles of herpesvirus miRNAs in latency and reacti-
vation, experiments in multiple in vivo systems have now
clearly demonstrated an essential role for viral miRNAs in
pathogenic outcomes. For example, within their respective
systems, miRNA mutants are severely attenuated for HSV-1
neurovirulence, MHV68 inflammatory pneumonia, and
MDV-1 lymphomagenesis. Moreover, studies with KSHV
K12-11 and EBV BART-7-3p validate the concept that
individual viral miRNAs can very significantly impact the
replication and metastatic potential of infected cells.
Although this theme does not apparently extend to the EBV
BHRF1-cluster miRNAs, other EBV miRNAs may con-
tribute to oncogenesis, and the EBV BART cluster 1 and 2
miRNAs are yet to be carefully tested in this system.
Based on the likelihood that viral miRNAs function in
a cell-type specific manner, and owing to the requirement
of target sequence specificity, it would seem that defining
the specific functions of these molecules in highly com-
plex in vivo systems will surely prove to be extremely
difficult. Nevertheless, the recent advances described here
have yielded critical new insight into the potent actions
of some viral miRNAs, and provide excitement for
the future of in vivo herpesvirus non-coding RNA
experimentation.
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